在KRAS驱动的癌症中,糖脂合成调解免疫逃避
Mariluz Soula1, Gokhan Unlu1, Rachel Welch1
1Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Nature
|August 7, 2024
概括
癌细胞使用脂合成来逃避免疫攻击. 抑制这种途径可以增强抗癌免疫力,并与治疗相协作,揭示糖脂是癌症免疫规避的关键标.
科学领域:
- 癌症生物学
- 免疫学
- 代谢途径
背景情况:
- 癌细胞重新编程脂质代谢以进行生长和适应.
- 特定脂质在瘤形成中的确切作用尚未完全理解.
- 脂质代谢对于膜功能,信号传递和能量产生至关重要.
研究的目的:
- 调查新脂合成在癌症免疫逃避中的作用.
- 确定参与瘤免疫逃避机制的特定脂质.
- 探索针对脂合成的治疗策略来治疗癌症.
主要方法:
- 使用了功能基因组学和脂质组学方法.
- 在癌细胞培养和小鼠模型 (共生和免疫缺陷) 中进行了实验.
- 分析了干扰素- (IFNγ) 信号通路.
主要成果:
- 在培养物或免疫缺陷小鼠中,新兴脂合成对癌症免疫逃避至关重要,但对癌症扩散至关重要.
- 通过IFNγ信号,阻断脂合成增强了天然杀手 (NK) 和CD8+T细胞的抗瘤作用.
- 糖脂的消耗会增加IFNγ受体子单元1 (IFNGR1) 的表面水平,从而导致IFNγ诱导的生长停止.
- 药理上抑制糖脂合成与检查点阻塞疗法产生协同作用.
结论:
- 糖脂是癌症免疫规避的必要和限制性代谢物.
- 针对新的脂合成是增强抗瘤免疫力的有希望的策略.
- 这一途径是克服癌症免疫逃避和改善治疗结果的关键目标.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


